Artwork

Content provided by Olumide Ogunsanwo and Bankole Makanju, Olumide Ogunsanwo, and Bankole Makanju. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Olumide Ogunsanwo and Bankole Makanju, Olumide Ogunsanwo, and Bankole Makanju or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

#38: 54gene - How the HealthTech platform is building diverse datasets to improve diagnostic and treatment outcomes across Africa

1:58:15
 
Share
 

Manage episode 303070928 series 2712808
Content provided by Olumide Ogunsanwo and Bankole Makanju, Olumide Ogunsanwo, and Bankole Makanju. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Olumide Ogunsanwo and Bankole Makanju, Olumide Ogunsanwo, and Bankole Makanju or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Overview: Today, we’re going to talk about 54gene - the genomics HealthTech company. We’ll explore the 54gene story across 6 areas:

  1. African Health care status & context
  2. 54gene early history
  3. Fundraising & Growth
  4. Product & monetization strategy
  5. Competitive positioning & potential exit options
  6. Overall outlook.

This episode was recorded on Sep 19, 2021

Companies discussed: 54gene, llumina, African Centre of Excellence for Genomics of Infectious Diseases, Y Combinator (YC), 50 Years, Bill & Melinda Gates Foundation, Gilead, IMS Health, Broad Institute, Novartis, Cathay AfricInvest, Helium Health & mPharma

Business concepts discussed: Genomics, Capacity development / Local knowledge development, Healthcare technology, Health insurance coverage, commercial biobanks & public policy

Conversation highlights:

  • (00:54) - Why we’re talking about 54Gene today
  • (06:25) - Context on Healthcare and Genomics in Africa
  • (27:02) - 54Gene founding and early history
  • (34:13) - Fundraising and early growth - Seed, Series A, Series B
  • (54:15) - Product and monetization strategy
  • (1:11:00) - 54Gene capacity building
  • (1:17:00) - Competition in this space, exit opportunities
  • (1:30:39) - Olumide’s overall thoughts and outlook
  • (1:42:38) - Bankole’s overall thoughts and outlook
  • (1:56:03) - Recommendations and small wins

Olumide’s recommendations & small wins:

Bankole’s recommendations & small wins:

Listeners: We’d love to hear from you. Email info@afrobility.com with feedback!

Founders: We'd love to hear about what you're working on, email us at info@afrobility.com

Investors: We'd also love to link up with you to drive the ecosystem forward. Contact us at info@afrobility.com

Join our insider mailing list where we get feedback on new episodes & find all episodes at Afrobility.com

  continue reading

77 episodes

Artwork
iconShare
 
Manage episode 303070928 series 2712808
Content provided by Olumide Ogunsanwo and Bankole Makanju, Olumide Ogunsanwo, and Bankole Makanju. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Olumide Ogunsanwo and Bankole Makanju, Olumide Ogunsanwo, and Bankole Makanju or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Overview: Today, we’re going to talk about 54gene - the genomics HealthTech company. We’ll explore the 54gene story across 6 areas:

  1. African Health care status & context
  2. 54gene early history
  3. Fundraising & Growth
  4. Product & monetization strategy
  5. Competitive positioning & potential exit options
  6. Overall outlook.

This episode was recorded on Sep 19, 2021

Companies discussed: 54gene, llumina, African Centre of Excellence for Genomics of Infectious Diseases, Y Combinator (YC), 50 Years, Bill & Melinda Gates Foundation, Gilead, IMS Health, Broad Institute, Novartis, Cathay AfricInvest, Helium Health & mPharma

Business concepts discussed: Genomics, Capacity development / Local knowledge development, Healthcare technology, Health insurance coverage, commercial biobanks & public policy

Conversation highlights:

  • (00:54) - Why we’re talking about 54Gene today
  • (06:25) - Context on Healthcare and Genomics in Africa
  • (27:02) - 54Gene founding and early history
  • (34:13) - Fundraising and early growth - Seed, Series A, Series B
  • (54:15) - Product and monetization strategy
  • (1:11:00) - 54Gene capacity building
  • (1:17:00) - Competition in this space, exit opportunities
  • (1:30:39) - Olumide’s overall thoughts and outlook
  • (1:42:38) - Bankole’s overall thoughts and outlook
  • (1:56:03) - Recommendations and small wins

Olumide’s recommendations & small wins:

Bankole’s recommendations & small wins:

Listeners: We’d love to hear from you. Email info@afrobility.com with feedback!

Founders: We'd love to hear about what you're working on, email us at info@afrobility.com

Investors: We'd also love to link up with you to drive the ecosystem forward. Contact us at info@afrobility.com

Join our insider mailing list where we get feedback on new episodes & find all episodes at Afrobility.com

  continue reading

77 episodes

すべてのエピソード

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide